InvestorsHub Logo

crudeoil24

05/05/14 9:53 AM

#48929 RE: micanwait #48928

The commencement of patient enrollment in Medinol’s clinical trials, along with the submission of an investigational device exemption with the U.S. Food and Drug Administration, triggers milestone payments to ARIAD of $3.75 million, with the potential for additional regulatory, clinical and sales milestones, as well as royalties on product sales.